Fernwood Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $407K | Sell |
2,660
-100
| -4% | -$16.9K | 0.14% | 119 |
|
|
2024
Q3 | $535K | Sell |
2,760
-120
| -4% | -$25.1K | 0.17% | 113 |
|
|
2024
Q2 | $668K | Sell |
2,880
-3
| -0.1% | -$652 | 0.21% | 92 |
|
|
2024
Q1 | $622K | Buy |
2,883
+3
| +0.1% | +$703 | 0.18% | 106 |
|
|
2023
Q4 | $745K | Hold |
2,880
| – | – | 0.25% | 88 |
|
|
2023
Q3 | $740K | Sell |
2,880
-200
| -6% | -$53.5K | 0.27% | 89 |
|
|
2023
Q2 | $877K | Sell |
3,080
-100
| -3% | -$29.8K | 0.31% | 87 |
|
|
2023
Q1 | $884K | Sell |
3,180
-1,250
| -28% | -$346K | 0.34% | 83 |
|
|
2022
Q4 | $1.23M | Sell |
4,430
-400
| -8% | -$113K | 0.51% | 62 |
|
|
2022
Q3 | $1.29M | Sell |
4,830
-209
| -4% | -$44.4K | 0.54% | 53 |
|
|
2022
Q2 | $1.03M | Hold |
5,039
| – | – | 0.44% | 68 |
|
|
2022
Q1 | $1.06M | Sell |
5,039
-215
| -4% | -$46.8K | 0.37% | 77 |
|
|
2021
Q4 | $1.26M | Buy |
5,254
+9
| +0.2% | +$2.31K | 0.41% | 69 |
|
|
2021
Q3 | $1.48M | Sell |
5,245
-15
| -0.3% | -$4.92K | 0.51% | 57 |
|
|
2021
Q2 | $1.82M | Sell |
5,260
-225
| -4% | -$68.2K | 0.6% | 47 |
|
|
2021
Q1 | $1.53M | Sell |
5,485
-75
| -1% | -$20.2K | 0.56% | 50 |
|
|
2020
Q4 | $1.36M | Hold |
5,560
| – | – | 0.54% | 54 |
|
|
2020
Q3 | $1.58M | Sell |
5,560
-1,200
| -18% | -$335K | 0.75% | 38 |
|
|
2020
Q2 | $1.81M | Hold |
6,760
| – | – | 0.89% | 31 |
|
|
2020
Q1 | $2.14M | Sell |
6,760
-1,220
| -15% | -$370K | 1.37% | 22 |
|
|
2019
Q4 | $2.37M | Sell |
7,980
-180
| -2% | -$49.9K | 1.13% | 29 |
|
|
2019
Q3 | $1.9M | Buy |
8,160
+375
| +5% | +$87.3K | 0.94% | 33 |
|
|
2019
Q2 | $1.82M | Sell |
7,785
-1,175
| -13% | -$271K | 1% | 31 |
|
|
2019
Q1 | $2.12M | Sell |
8,960
-25
| -0.3% | -$7.87K | 1.13% | 24 |
|
|
2018
Q4 | $2.7M | Sell |
8,985
-50
| -0.6% | -$16K | 1.74% | 10 |
|
|
2018
Q3 | $3.19M | Sell |
9,035
-40
| -0.4% | -$13.8K | 1.69% | 10 |
|
|
2018
Q2 | $2.63M | Sell |
9,075
-100
| -1% | -$28.1K | 1.42% | 14 |
|
|
2018
Q1 | $2.51M | Sell |
9,175
-500
| -5% | -$155K | 1.4% | 14 |
|
|
2017
Q4 | $3.08M | Sell |
9,675
-225
| -2% | -$72.2K | 1.65% | 10 |
|
|
2017
Q3 | $3.1M | Buy |
9,900
+100
| +1% | +$29.6K | 1.94% | 9 |
|
|
2017
Q2 | $2.66M | Hold |
9,800
| – | – | 1.93% | 9 |
|
|
2017
Q1 | $2.68M | Sell |
9,800
-180
| -2% | -$50.9K | 2.13% | 9 |
|
|
2016
Q4 | $2.83M | Sell |
9,980
-75
| -0.7% | -$22.2K | 2.71% | 6 |
|
|
2016
Q3 | $3.15M | Buy |
10,055
+100
| +1% | +$29.6K | 2.88% | 6 |
|
|
2016
Q2 | $2.41M | Sell |
9,955
-100
| -1% | -$26.4K | 2.36% | 8 |
|
|
2016
Q1 | $2.62M | Sell |
10,055
-1,750
| -15% | -$462K | 2.65% | 6 |
|
|
2015
Q4 | $3.62M | Buy |
11,805
+400
| +4% | +$115K | 3.09% | 5 |
|
|
2015
Q3 | $3.33M | Buy |
11,405
+25
| +0.2% | +$8.26K | 2.92% | 6 |
|
|
2015
Q2 | $4.6M | Buy |
11,380
+500
| +5% | +$201K | 3.61% | 4 |
|
|
2015
Q1 | $4.59M | Sell |
10,880
-390
| -3% | -$154K | 3.78% | 4 |
|
|
2014
Q4 | $3.83M | Buy |
11,270
+1,665
| +17% | +$539K | 3.25% | 4 |
|
|
2014
Q3 | $3.18M | Sell |
9,605
-160
| -2% | -$52.8K | 2.73% | 7 |
|
|
2014
Q2 | $3.08M | Sell |
9,765
-400
| -4% | -$120K | 2.54% | 6 |
|
|
2014
Q1 | $3.11M | Sell |
10,165
-3,600
| -26% | -$1.14M | 2.88% | 4 |
|
|
2013
Q4 | $3.85M | Buy |
+13,765
| New | +$3.56M | 2.56% | 5 |
|
Other funds holding BIIB
Fernwood Investment Management's BIIB Position: Q4 2024 in Review
Fernwood Investment Management reduced its Biogen (BIIB) stake by 3.6% in Q4 2024, selling an estimated $16.9K and leaving 2,660 shares worth $407K. The position accounts for 0.14% of the portfolio, ranked #119.
Fernwood Investment Management first reported a position in BIIB in Q4 2013 and has held it in 45 quarters since. The position peaked at $4.6M in Q2 2015. 875 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.
- Fernwood Investment Management held 2,660 shares of Biogen worth $407K as of Q4 2024.
- Fernwood Investment Management sold 100 Biogen shares in Q4 2024, an estimated $16.9K.
- Biogen made up 0.14% of Fernwood Investment Management's portfolio in Q4 2024, its #119 holding.
- Fernwood Investment Management first reported a position in Biogen in Q4 2013 and has held it in 45 quarters since.
- Fernwood Investment Management's Biogen position peaked at $4.6M in Q2 2015.
- 875 funds tracked by Wall St. Rank held Biogen as of Q4 2024.
Based on Fernwood Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.